BPC-157 is not approved by the Therapeutic Goods Administration (TGA) and is prohibited by the World Anti-Doping Agency (WADA)
Supports skin clarity and improves its overall appearance with regular use
Look for suppliers offering OEM or custom formulation services tailored to wholesale and distributor trends
CHST14 EDS/musculocontractural EDS The features of this rare condition (MIM 601776) include progressive kyphoscoliosis, adducted thumbs in infancy, clubfoot, arachnodactyly, joint hypermobility, fragile and hyperextensible skin with atrophic scars and delayed wound healing.20 22 Arthrochalasic EDS Arthrochalasic EDS (MIM 130060) is extremely rare.23 Congenital bilateral hip dislocation, severe joint hypermobility with recurrent dislocations, skin hyperextensibility, easy bruising, atrophic scars, kyphoscoliosis and osteopaenia are the features of this autosomal-dominant condition
No completed human Phase 2/3 trials